Krishna Kalghatgi

Title: Krishna Kalghatgi: Innovator in Drug Discovery and Development

Introduction

Krishna Kalghatgi, based in Westborough, MA, is an accomplished inventor with a remarkable portfolio of six patents. His innovative contributions primarily focus on drug discovery and the development of therapeutic solutions targeting specific medical conditions.

Latest Patents

Among Krishna's latest patents is the invention entitled "Assay for PCSK9 inhibitors." This invention outlines methods for identifying modulators of PCSK9, which can provide vital treatment options for diseases such as hyperlipidemia and related disorders. Another significant patent is his "Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation." This invention describes a method for identifying ligands for biomolecules from mass-coded combinatorial libraries, offering new avenues for drug development.

Career Highlights

Throughout his career, Krishna has worked in notable companies, including Schering Corporation and Neogenesis Drug Discovery, Inc. His experiences in these organizations have provided him with a strong foundation in pharmaceuticals and the biotechnological landscape, enabling him to drive innovations that impact healthcare.

Collaborations

Krishna has collaborated with prominent colleagues such as Satish Jindal and Huw M Nash. These partnerships have fostered creativity and enhanced the development of groundbreaking inventions within the realms of drug discovery and therapeutic advancements.

Conclusion

As an inventor, Krishna Kalghatgi has made substantial contributions to the field of medicine through his patents and collaborations. His work continues to inspire further innovation, providing hope for patients suffering from various medical conditions.